DEBORAH KING: Open Payments
NPI 1265057129 · WEST PLAINS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$155 in 8 payments from 7 companies in 2025. Trend: 2023 $56 · 2024 $137 · 2025 $155
Food & beverage: $120Long term medical supply or device loan: $36
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $36 |
| Baxter Healthcare | 1 | $36 |
| Dexcom, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Ozempic, Hillrom - Spot Vision Screener, Dexcom G6 Transmitter, TRELEGY ELLIPTA, JARDIANCE, ROTATEQ, BREZTRI.
Industry payments across MO — which companies pay providers there.
